Skip to content

BIOAGE LABS, INC.

BIOA

CIK 0001709941

← back to feed
Revenue (TTM)
$8.69M
Q1 May 2026
Net Income (TTM)
−$76.92M
−13.4% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.04
+66.2% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-1,032.7%
Q1 May 2026
Net Margin
-885.2%
Q1 May 2026
Free Cash Flow (TTM)
−$82.35M
Q1 May 2026
Cash
$241.78M
Q1 May 2026
Total Debt
$1.16M
Q1 May 2026
Shares Outstanding
44.45M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings